OMNasdaqElectromedical & Electrotherapeutic ApparatusFiscal year ends December 31
Outset Medical, Inc.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 6, 2026
$3.80−0.14 (-3.55%)
Close on Oct 19, 2026
- Market cap
- $70.75K
- P/E (TTM)
- –
- Dividend yield
- –
Outset Medical, Inc. revenue by segment
By business segment
By product or service
| Revenue | TTM Q2 26 | TTM Q1 26 | TTM Q4 25 | TTM Q3 25 | TTM Q2 25 | TTM Q1 25 | TTM Q4 24 | TTM Q3 24 | TTM Q2 24 | TTM Q1 24 | TTM Q4 23 | TTM Q3 23 | % of revenue | YoY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Product Revenue | $80.89M | $82.06M | $84.81M | $85.94M | $85.69M | $81.84M | $80.98M | $82.87M | $86.09M | $96.19M | $103.54M | $107.00M | 68.7% | -5.6% |
| Consumables Product | $51.32M | $53.05M | $54.08M | $55.83M | $56.20M | $54.13M | $51.15M | $48.51M | $46.94M | $44.51M | $42.21M | $37.59M | 43.6% | -8.7% |
| Service and Other Revenue | $36.91M | $35.52M | $34.67M | $34.13M | $33.62M | $33.43M | $32.71M | $31.86M | $30.33M | $28.89M | $26.84M | $24.87M | 31.3% | +9.8% |
| Consoles Product | $29.57M | $29.01M | $30.73M | $30.11M | $29.48M | $27.71M | $29.83M | $34.36M | $39.16M | $51.68M | $61.33M | $69.41M | 25.1% | +0.3% |
By region
From the segment and revenue-disaggregation notes of Outset Medical's 10-K and 10-Q filings (XBRL). Fourth-quarter figures are the fiscal year less the first nine months. Segment names follow the company's own labels and can change when it reorganizes.